Condition
Cardiac MRI
Total Trials
5
Recruiting
0
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (4)
P 4 (1)
Trial Status
Completed3
Active Not Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04967807Not ApplicableActive Not Recruiting
Myocardial Injury and Outcomes Following COVID-19 Vaccination (MYOVAX Study)
NCT03661827Not ApplicableCompleted
Dobutamine vs Adenosine CMR Study
NCT03031587Not ApplicableCompletedPrimary
Validation of Thermometric Cardiac Imaging by MRI
NCT05103852Not ApplicableUnknownPrimary
Feasibility, Safety and Diagnostic Input of Interventional Cardiac MRI on a Series of 35 Patients With an Indication of Right Cardiac Catheterization.
NCT02655770Phase 4Completed
Effect of Liraglutide on Diastolic Dysfunction on Cardiac MRI in Type 2 Diabetes Patients
Showing all 5 trials